Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1

Status

Unknown 6Completed 5Recruiting 3Active not recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 192Neoplasms 148Prostatic Neoplasms 101Lung Neoplasms 90Carcinoma, Non-Small-Cell Lung 62Colorectal Neoplasms 59Head and Neck Neoplasms 52Pancreatic Neoplasms 46Carcinoma, Hepatocellular 44Rectal Neoplasms 42Brain Neoplasms 41Multiple Myeloma 40Colonic Neoplasms 37Esophageal Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Neoplasm Metastasis 30Leukemia, Myeloid, Acute 30Ovarian Neoplasms 29Lymphoma, Non-Hodgkin 29Leukemia 29Lymphoma 28Motor Activity 26Hodgkin Disease 24Uterine Cervical Neoplasms 23Carcinoma, Renal Cell 23Pain 22Lymphoma, Follicular 22Depression 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioma 21

Interventions

Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Terminated × Renal Insufficiency × Clear all
NCT02360111 2019-07-24

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase NA Terminated
3 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡